Amonafide L-malate is not a substrate for multidrug resistance proteins in secondary acute myeloid leukemia

Leukemia

Volumn 22, Issue 11, 2008, Pages 2110-2115

  Burcu, M ^a   O'Loughlin, K L ^b   Ford, L A ^b   Baer, M R ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMONAFIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; GLYCOPROTEIN P; IDARUBICIN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; DRUG EFFICACY; DRUG TARGETING; DRUG TRANSPORT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN FUNCTION; TREATMENT FAILURE; TREATMENT RESPONSE;

EID: 56249083538     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.87     Document Type: Article

References (7)

1. Mahadevan D, List AF. Targeting the multidrug resistance-1 transporter in AML: Molecular regulation and therapeutic strategies. Blood 2004; 104: 1940-1951.
2. Steinbach D, Legrand O. ABC transporters and drug resistance in leukemia: Was Pgp nothing but the first head of the Hydra? Leukemia 2007; 21: 1172-1176.
3. Allen SL, Kolitz JE, Lundberg AS, Capizzi RL, Budman DR. Clinical and cytogenetic responses to amonafide in secondary acute myeloid leukemia (AML). J Clin Oncol 2006; 24: 6584 (abstract).
4. Erba HP, Rizzieri DA, O'Donnell MR, Lundberg AS, Ajami AM, Rampersad AD et al. Amonafide and ara-C treatment for secondary acute myeloid leukemia (sAML). J Clin Oncol 2007; 25: 7065 (abstract).
5. Chau M, Christensen JL, Ajami AM, Capizzi RL. Amonafide, a topoisomerase II inhibitor, is unaffected by P-glycoprotein-mediated efflux. Leuk Res 2008; 32: 465-473.
6. Suvannasankha A, Minderman H, O'Loughlin KL, Nakanishi T, Greco WR, Ross DD et al. Breast cancer resistance protein in acute myeloid leukemia: Discordance between expression and function. Leukemia 2004; 18: 1252-1257.
7. Qadir M, O'Loughlin KL, Fricke SM, Williamson NA, Greco WR, Minderman H et al. Cyclosporin A is a broad-spectrum multidrug resistance modulator. Clin Cancer Res 2005; 11: 2320-2326.